These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37890724)

  • 1. MASLD vs. NAFLD: A better definition for children with obesity at higher risk of kidney damage.
    Di Sessa A; Guarino S; Umano GR; Miraglia Del Giudice E; Marzuillo P
    J Hepatol; 2024 Feb; 80(2):e87-e89. PubMed ID: 37890724
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease.
    Semmler G; Balcar L; Wernly S; Völkerer A; Semmler L; Hauptmann L; Wernly B; Aigner E; Niederseer D; Datz C
    Front Endocrinol (Lausanne); 2023; 14():1244405. PubMed ID: 37842290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steatotic liver disease, MASLD and risk of chronic kidney disease.
    Bilson J; Mantovani A; Byrne CD; Targher G
    Diabetes Metab; 2024 Jan; 50(1):101506. PubMed ID: 38141808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
    Mohamed RZ; Jalaludin MY; Anuar Zaini A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we use old NAFLD data under the new MASLD definition?
    Song SJ; Lai JC; Wong GL; Wong VW; Yip TC
    J Hepatol; 2024 Feb; 80(2):e54-e56. PubMed ID: 37541393
    [No Abstract]   [Full Text] [Related]  

  • 7. Pediatric Non-alcoholic Fatty Liver Disease.
    Uppal V; Mansoor S; Furuya KN
    Curr Gastroenterol Rep; 2016 May; 18(5):24. PubMed ID: 27086005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing from NAFLD to MASLD: The new definition can more accurately identify individuals at higher risk for diabetes.
    He L; Zheng W; Qiu K; Kong W; Zeng T
    J Hepatol; 2024 Feb; 80(2):e85-e87. PubMed ID: 37827469
    [No Abstract]   [Full Text] [Related]  

  • 9. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.
    Eslam M; Alkhouri N; Vajro P; Baumann U; Weiss R; Socha P; Marcus C; Lee WS; Kelly D; Porta G; El-Guindi MA; Alisi A; Mann JP; Mouane N; Baur LA; Dhawan A; George J
    Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):864-873. PubMed ID: 34364544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.
    Leoni S; Tovoli F; Napoli L; Serio I; Ferri S; Bolondi L
    World J Gastroenterol; 2018 Aug; 24(30):3361-3373. PubMed ID: 30122876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".
    Fang YL; Chen H; Wang CL; Liang L
    World J Gastroenterol; 2018 Jul; 24(27):2974-2983. PubMed ID: 30038464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD.
    Fukunaga S; Mukasa M; Nakano D; Tsutsumi T; Kawaguchi T
    Clin Mol Hepatol; 2024 Jan; 30(1):121-123. PubMed ID: 38044039
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage.
    Zhou L; Zhang L; Zhang L; Yi W; Yu X; Mei H; Xiao H; Wang Y; Qin H; Xiong X; Yan S; Dong H; Chen P; Chen X
    Front Endocrinol (Lausanne); 2023; 14():1224816. PubMed ID: 37720532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detecting non-alcoholic fatty liver in children with owerweight and obesity.].
    García-López NA; Jiménez-Álvarez A; Murillo-Zamora E
    Rev Med Inst Mex Seguro Soc; 2021 Nov; 59(6):465-472. PubMed ID: 34905320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.
    Mansour-Ghanaei F; Joukar F; Mobaraki SN; Mavaddati S; Hassanipour S; Sepehrimanesh M
    Diabetes Metab Syndr; 2019; 13(2):1591-1596. PubMed ID: 31336526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal obesity increases the risk and severity of NAFLD in offspring.
    Hagström H; Simon TG; Roelstraete B; Stephansson O; Söderling J; Ludvigsson JF
    J Hepatol; 2021 Nov; 75(5):1042-1048. PubMed ID: 34289397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease.
    Rinella ME; Castro Narro GE; Krag A; Terrault N; Newsome PN
    J Hepatol; 2024 Jul; 81(1):e20-e21. PubMed ID: 38906627
    [No Abstract]   [Full Text] [Related]  

  • 18. [Non-alcoholic steatohepatitis (NASH) : a model of metabolic inflammation («metaflammation»)].
    Scheen AJ; Luyckx FH; Esser N; Lamproye A; Delwaide J; Paquot N
    Rev Med Liege; 2022 May; 77(5-6):316-322. PubMed ID: 35657189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty liver disease and obesity in youth.
    Della Corte C; Mazzotta AR; Nobili V
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):66-71. PubMed ID: 26702852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnostics and clinical pattern of nonalcoholic fatty liver disease in patients with pre-diabetes and type 2 diabetes and obesity].
    Чубірко КІ
    Wiad Lek; 2017; 70(2):208-212. PubMed ID: 28511161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.